| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 7,494,876 | 6,718,368 | 7,950,268 | 7,497,660 | | Cost of Revenue | 3,128,998 | 2,935,921 | 3,178,381 | 3,352,869 | | | Gross Profit | 4,365,878 | 3,782,447 | 4,771,887 | 4,144,791 | | | Operating Expenses | | Research Development | 670,206 | 650,743 | 731,631 | 680,360 | | Selling General and Administrative | 2,024,252 | 2,070,945 | 2,297,360 | 2,067,914 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,671,420 | 1,060,759 | 1,742,896 | 1,396,517 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 32,587 | 995,910 | (52,530) | 101,533 | | Earnings Before Interest And Taxes | 1,704,007 | 2,056,669 | 1,809,363 | 1,498,050 | | Interest Expense | 136,969 | 124,190 | 123,157 | 125,014 | | Income Before Tax | 1,567,038 | 1,932,479 | 1,686,206 | 1,373,036 | | Income Tax Expense | 278,933 | 493,842 | 296,483 | 288,424 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,288,105 | 1,438,637 | 1,389,723 | 1,084,612 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| 146,503 |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,288,105 | 1,438,637 | 1,536,226 | 1,084,612 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,288,105 | $1,438,637 | $1,536,226 | $1,084,612 |
|
2.03% Nasdaq 
Income Statement
